(19)
(11) EP 1 165 093 A1

(12)

(43) Date of publication:
02.01.2002 Bulletin 2002/01

(21) Application number: 00913730.8

(22) Date of filing: 02.03.2000
(51) International Patent Classification (IPC)7A61K 31/70, A61K 48/00, A61K 49/00, C07H 21/00, C12N 15/63
(86) International application number:
PCT/US0005/643
(87) International publication number:
WO 0051/621 (08.09.2000 Gazette 2000/36)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 05.03.1999 US 122950 P

(71) Applicant: Epigenesis Pharmaceuticals, Inc.
Cranbury, NJ 08520 (US)

(72) Inventor:
  • NYCE, Jonathan, W.
    Princeton, NY 08540 (US)

(74) Representative: Becker Kurig Straus 
Patentanwälte Bavariastrasse 7
80336 München
80336 München (DE)

   


(54) METHOD FOR VALIDATING/INVALIDATING TARGET(S) AND PATHWAYS